Roshan Timsina1, Upasana Shrestha2, Anjana Singh1, Bivek Timalsina2. 1. Central Department of Microbiology, Tribhuvan University, Kathmandu, Nepal. 2. Center for Health & Disease Studies-Nepal (CHDS), Shankhamul, Kathmandu, Nepal.
Abstract
AIM: Resistance to methicillin and Macrolide-Lincosamide and Streptogramins B and their association with erm genes in Staphylococcus aureus are unknown in Nepal. MATERIALS & METHODS: Nonduplicate nasal swabs from 160 school children were collected from April to September 2018 and processed using standard microbiological procedures. RESULTS: Out of 160 samples, 64 (40%) were S. aureus in which 17 (26.6%) were methicillin-resistance Staphylococcus aureus (MRSA). D-test identified 15 (23.4%) as inducible clindamycin-resistant, which were more prevalent in MRSA (76.4%) than methicillin-sensitive S. aureus (MSSA; 4.2%). 18.7% of isolates harbored the ermC gene followed by ermA (15.6%) and ermB (3.1%), and were more in MRSA than MSSA. CONCLUSION: To prevent treatment failure by inducible resistance, D-test must be performed on erythromycin-resistant and/or clindamycin-sensitive isolates.
AIM: Resistance to methicillin and Macrolide-Lincosamide and Streptogramins B and their association with erm genes in Staphylococcus aureus are unknown in Nepal. MATERIALS & METHODS: Nonduplicate nasal swabs from 160 school children were collected from April to September 2018 and processed using standard microbiological procedures. RESULTS: Out of 160 samples, 64 (40%) were S. aureus in which 17 (26.6%) were methicillin-resistance Staphylococcus aureus (MRSA). D-test identified 15 (23.4%) as inducible clindamycin-resistant, which were more prevalent in MRSA (76.4%) than methicillin-sensitive S. aureus (MSSA; 4.2%). 18.7% of isolates harbored the ermC gene followed by ermA (15.6%) and ermB (3.1%), and were more in MRSA than MSSA. CONCLUSION: To prevent treatment failure by inducible resistance, D-test must be performed on erythromycin-resistant and/or clindamycin-sensitive isolates.
Authors: Todd P Levin; Byungse Suh; Peter Axelrod; Allan L Truant; Thomas Fekete Journal: Antimicrob Agents Chemother Date: 2005-03 Impact factor: 5.191